Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 9/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 7/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.38 |
| ▸ | LMNA | P02545 | 3/20 | 0.38 |
| ▸ | GAA | P10253 | 3/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | HPGD | P15428 | 2/20 | 0.35 |
| ▸ | PKM | P14618 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 6/20 | 0.35 |
| ▸ | NPC1 | O15118 | 4/20 | 0.35 |
| ▸ | HTT | P42858 | 3/20 | 0.34 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20148188 | 0.90 | L3MBTL1 (0.44) | L3MBTL1MAPTSMN1; SMN2KDM4EALDH1A1 | |
| SCHEMBL20151074 | 0.84 | GAA (0.36) | L3MBTL1MAPTSMN1; SMN2KDM4EALDH1A1 | |
| SCHEMBL20151076 | 0.77 | KDM4E (0.33) | L3MBTL1MAPTKDM4EALDH1A1GAA | |
| SCHEMBL20150970 | 0.77 | KDM4E (0.33) | MAPTKDM4EMEN1KMT2A | |
| SCHEMBL20151073 | 0.77 | MAPT (0.46) | MAPTSMN1; SMN2KDM4EALDH1A1LMNA | |
| SCHEMBL20150963 | 0.76 | POLB (0.57) | KDM4ELMNAMEN1KMT2AHTT | |
| SCHEMBL20150968 | 0.75 | CTH (0.40) | MAPTSMN1; SMN2KDM4ELMNAMEN1 | |
| SCHEMBL20150967 | 0.74 | GAA (0.35) | L3MBTL1MAPTSMN1; SMN2KDM4EALDH1A1 | |
| SCHEMBL20151064 | 0.74 | GAA (0.31) | L3MBTL1MAPTKDM4EALDH1A1GAA | |
| SCHEMBL20150971 | 0.72 | CTH (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240067860-A1 | COMPOSITIONS AND METHODS FOR CARBON DIOXIDE SOLIDIFICATION | CHEVRON U.S.A. INC. | 2024-02-29 | — | — | US | disclosed |
| US-10633332-B2 | Guanidine compounds for removal of oxyanions from aqueous solutions and for carbon dioxide capture | UT-BATTELLE, LLC (US) | 2020-04-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10633332-B2 | Guanidine compounds for removal of oxyanions from aqueous solutions and for carbon dioxide capture | GUCY1A1, GUCY1A2, GUCY1B1 | L3MBTL1 2462/4885MAPT 2656/4885SMN1; SMN2 1131/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.